1 of 4
/NVIDIA%20Corp%20video%20chip-by%20Antonio%20Bordunovi%20via%20iStock.jpg)
/Nvidia%20logo%20and%20sign%20on%20headquarters%20by%20Michael%20Vi%20via%20Shutterstock.jpg)
/Cybersecurity%20by%20AIBooth%20via%20Shutterstock.jpg)
KeyBanc says Zscaler stock is not out of juice just yet. Here’s why its analyst recommends buying ZS shares heading into the Q4 earnings on Sept. 3.
TG Therapeutics stock rips higher on takeover speculation. But should you chase the momentum on Friday? Let’s find out!
Broadcom is building a massive AI financing machine that could unlock chip demand, accelerate revenue, and strengthen its edge in custom silicon—though credit risks remain.
/A%20close-up%20of%20the%20Broadcom%20logo%20on%20a%20smartphone%20by%20Timon%20via%20Adobe%20Stock.jpeg)
BMO initiates coverage on Broadcom stock with an "Outperform" rating. Here’s how high it believes AVGO shares could fly in 2026.
Nike stock recently fell to a 12-year low and has lost almost $200 billion in market cap from the November 2021 highs. While not a real bargain yet, the stock has started to look attractive at these levels....
Not even Wall Street titans make the right call every single time. But Michael Burry's bad timing isn't just a cautionary tale for bearish investors.
Cleveland-Cliffs stock rallies on plans of $1 billion investment in Middletown Works facility. Here’s why the announcement is bullish for CLF shares.
/AI%20(artificial%20intelligence)/AI%20Infrastructure%20by%20FOTOGRIN%20via%20Shutterstock.jpg)
The investment firm has added to its Hut 8 investment amid the AI boom.
/Moderna%20Inc%20HQ-by%20hapabapa%20via%20iStock.jpg)
Moderna's cancer treatment could treat more than just Melanoma, though the stock's momentum is already stalling. Should you still buy the dip?
